Specimen collection is the process of obtaining biological material from a person, animal, or environment so it can be tested, analyzed, or stored for future use. It sounds straightforward, but the way a specimen is gathered, handled, and transported has an outsized effect on the accuracy of any result that follows. Most errors in clinical laboratory testing happen before a sample ever reaches the analyzer, during what labs call the pre-analytical phase, and those mistakes can lead to misdiagnosis, unnecessary treatments, or missed diseases entirely.
Why Mistakes Before the Test Matter Most
A laboratory test has three phases: what happens before analysis (collecting, labeling, transporting the sample), the analysis itself, and interpreting the result. For decades, researchers and lab professionals focused on improving the machines and chemical assays that do the measuring. Over time, though, it became clear that the analytical phase is actually the most reliable step. The lion’s share of laboratory errors originate in the pre-analytical phase, and that realization has shifted quality-improvement efforts toward the collection process itself.1PubMed Central. Preanalytical Errors in Clinical Laboratory Testing at a Glance: Source and Control Measures
The mistakes that happen during this phase are varied: mislabeling a tube so that one patient’s blood gets attributed to another person, drawing a sample with the wrong technique, leaving it sitting too long before it reaches the lab, or exposing it to the wrong temperature. Any of these can produce results that look perfectly valid on paper but are dangerously wrong. A false positive might mean a patient receives medication they do not need; a false negative might mean a serious condition goes undetected.2International Journal of Computational and Experimental Science and Engineering. Pre-Analytical Laboratory Errors and Their Impact on Diagnostic Accuracy
Blood Collection and the Problem of Hemolysis
Blood is the most commonly collected clinical specimen, and the most common problem that plagues blood samples is hemolysis, the rupturing of red blood cells. When red cells break open, their contents spill into the surrounding fluid and interfere with measurements of potassium, liver enzymes, and many other analytes. The result can look like a patient has a dangerously high potassium level when their actual potassium is perfectly normal. Hemolysis that occurs outside the body is usually caused by the collection technique or how the sample is handled afterward, while hemolysis that occurs inside the body reflects actual medical conditions and is not a collection error.3PubMed Central. Hemolyzed Specimens: Major Challenge for Identifying and Rejecting Specimens in Clinical Laboratories
Several specific collection factors consistently drive up hemolysis rates. Drawing blood through an intravenous catheter rather than a standard needle stick, choosing puncture sites away from the inner elbow, applying a tourniquet for more than a minute, underfilling collection tubes, and shaking tubes too vigorously all increase the odds of rupturing cells.4PubMed. Key factors influencing the incidence of hemolysis: A critical appraisal of current evidence Emergency departments consistently see higher hemolysis rates than outpatient labs, partly because blood is often drawn through IV lines in urgent situations and partly because the people drawing blood in an emergency setting may not be dedicated phlebotomists.4PubMed. Key factors influencing the incidence of hemolysis: A critical appraisal of current evidence Transporting samples through pneumatic tube systems (the pressurized capsules that zoom through hospital ceilings) also raises hemolysis rates compared to carrying samples by hand.5PubMed. Causes, consequences and management of sample hemolysis in the clinical laboratory
Another classic concern in blood collection is the order in which different-colored tubes are filled. Each tube contains a different additive: one might have an anticoagulant, another a clot activator. The fear has long been that drawing tubes in the wrong sequence contaminates one tube’s additive with another’s, skewing test results. A systematic review of the evidence found that this cross-contamination risk is real for open collection systems (where blood flows freely into a tube) but negligible when using the closed vacuum-based systems now standard in most clinical settings.6PubMed Central. The Order of Draw during Blood Collection: A Systematic Literature Review A separate study confirmed this directly, finding that the anticoagulant EDTA was undetectable in samples regardless of draw order when closed tubes were used.7PubMed. Effect of order of draw of blood samples during phlebotomy on routine biochemistry results Despite this, many laboratories still train staff to follow a strict order of draw as a precaution, which is reasonable when the cost of compliance is low and the worst-case consequence of contamination is a wrong result.
Tissue Specimens and the Race Against the Clock
When a surgeon removes a tissue sample during a biopsy or cancer surgery, that tissue begins to degrade the moment it loses its blood supply. The time between removal from the body and either freezing or placement into a chemical preservative like formalin is called cold ischemia time, and professional guidelines for breast cancer specimens recommend keeping it under sixty minutes. If tissue sits too long, proteins on its surface can break down, and the immunohistochemistry stains that pathologists use to guide treatment decisions may give false-negative results.
A study of breast cancer specimens found that cases testing positive for estrogen receptors on the initial biopsy sometimes flipped to negative on the larger excision specimen, with a false-negative rate for estrogen receptors of about 11% and for progesterone receptors of about 14%.8PubMed Central. The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast Carcinoma Those discrepancies can change whether a patient receives hormone therapy. Interestingly, when researchers examined the same question in endometrial cancer, they found no significant differences in biomarker expression based on cold ischemia time, suggesting that sensitivity to handling varies by tumor type.9Gynecologic Oncology. Impact of cold ischemia time and formalin fixation time on biomarker expression in endometrial cancer The takeaway is that guidelines built on data from one cancer type do not automatically apply everywhere, and some tissues are more forgiving than others.
Urine, Stool, and Other Non-Blood Specimens
Not all specimens require a needle. Urine is probably the most familiar non-invasive clinical specimen, routinely collected for pregnancy tests, drug screening, kidney function panels, and urinary tract infection diagnosis. The persistent challenge with urine cultures is contamination. Skin bacteria, vaginal flora, and other organisms can enter the sample during collection and grow in the culture dish, producing results that look like a urinary infection but actually reflect poor technique. In one randomized trial comparing different clean-catch urine collection methods in an emergency department, contamination rates ranged from about 22% to 35% regardless of the specific instructions given, and no single method was statistically better than the others.10PubMed. Contamination in Adult Midstream Clean-Catch Urine Cultures in the Emergency Department: A Randomized Controlled Trial That is a sobering finding: roughly a quarter to a third of urine cultures in an emergency setting may be unreliable.
Dedicated collection devices, however, can help. One study in women found that a specialized urine collection device reduced mixed-growth contamination by about 36% compared to standard midstream collection and cut the need for repeat testing by about 31%.11PubMed. A novel midstream urine-collection device reduces contamination rates in urine cultures amongst women Women face higher baseline contamination rates due to anatomy, so a targeted collection tool makes a measurable difference.
Stool specimens present a different set of challenges, particularly in microbiome research, where the goal is to capture a representative snapshot of the trillions of bacteria in the gut. How you collect and preserve a stool sample changes what you find. Researchers have shown that collecting stool into commercial stabilization tubes produces a different bacterial composition profile than immediately freezing the same sample.12PubMed Central. Fecal sample collection methods and time of day impact microbiome composition and short chain fatty acid concentrations Even the time of day the sample is collected matters. For large-scale microbiome studies, these differences are not trivial: they can obscure real biological signals or create false associations between gut bacteria and disease.
Liquid Biopsy and the Rise of Cell-Free DNA
One of the fastest-growing areas in specimen collection involves capturing fragments of tumor DNA that circulate freely in the bloodstream. This approach, known as liquid biopsy, lets clinicians look for cancer markers with a simple blood draw instead of an invasive tissue biopsy. Circulating tumor DNA carries the same mutations as the primary tumor and can be used for early cancer detection, tracking how a tumor responds to treatment, and monitoring for recurrence after surgery.13PubMed Central. Circulating tumor DNA laboratory processes and clinical applications in nasopharyngeal carcinoma Higher levels of circulating tumor DNA tend to correlate with greater tumor burden and worse prognosis, while clearance during treatment is a favorable sign.14PubMed Central. Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives
The catch is that cell-free DNA and RNA are fragile. White blood cells in a standard blood tube continue to break apart after the draw, releasing their own genetic material and swamping the tiny signal from tumor-derived fragments. Standard blood tubes using the common anticoagulant EDTA show massive increases in background RNA within days. In one study, a marker gene showed a 22-fold increase in background RNA copies after three days in standard tubes, while specialized stabilization tubes limited that increase to just 1.5-fold.15Clinical Biochemistry. Stabilization of cell-free RNA in blood samples using a new collection device Specialized collection tubes that contain preservatives to prevent white blood cell breakdown have been developed specifically for this purpose, and they hold background RNA levels nearly flat even when shipped at temperatures up to 30°C for several days.16PubMed Central. A novel blood collection device stabilizes cell-free RNA in blood during sample shipping and storage Without the right tube, a perfectly performed blood draw yields an unusable sample for liquid biopsy. The collection device is not a minor detail; it is the difference between a meaningful result and noise.
Biobanking and the Limits of Freezing
Biobanks store millions of blood, tissue, and DNA samples at ultra-low temperatures so they can be used in future research, sometimes decades after collection. The assumption is that freezing suspends biology and preserves the specimen indefinitely, but every time a sample is removed from the freezer, thawed for use, and refrozen, some degradation occurs. How much degradation depends heavily on what you are measuring.
For plasma chemistry, the news is mostly reassuring. In a large-scale study from a Norwegian biobank, most analytes showed no significant change through 10 freeze-thaw cycles. Triglycerides and cholesterol began to drift after 10 cycles, dropping by roughly 17% and 6%, respectively. Free fatty acids were the most unstable, rising measurably with each cycle.17PubMed Central. Evaluation of Freeze Thaw Cycles on stored plasma in the Biobank of the Norwegian Mother and Child Cohort Study For genetic material in solid tissue, DNA and RNA in colorectal cancer specimens remained intact through nine freeze-thaw cycles, while protein expression patterns shifted significantly after seven cycles.18PubMed Central. Impact of Cold Ischemic Time and Freeze-Thaw Cycles on RNA, DNA and Protein Quality in Colorectal Cancer Tissues Biobanking
RNA in blood-based specimens is a different story. One investigation found that a single freeze-thaw episode from ultra-cold storage reduced DNA yield in plasma by about 25%, while another showed that after just three freeze-thaw cycles, amplifiable RNA in serum could no longer be detected.19PubMed Central. The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings The practical implication for biobanks is that they need to aliquot, or divide, specimens into small single-use portions at the time of initial processing. That way, researchers can thaw only what they need without subjecting the rest to another cycle.
Collecting Specimens from the Environment
Specimen collection extends well beyond hospitals. Ecologists now routinely filter water from rivers, lakes, and oceans to capture environmental DNA (eDNA), tiny fragments shed by fish, amphibians, and other organisms. Analyzing these fragments reveals which species live in a body of water without needing to catch or even see them. But the same fragility that makes cell-free DNA tricky in clinical settings applies here: eDNA degrades quickly in water, and how you filter, store, and extract it matters enormously.
A study comparing collection and storage methods recommended cellulose nitrate filters extracted with a commercial DNA kit, and found that filters could be stored frozen or placed in ethanol for up to four days without significant loss of DNA. The researchers also found that if you cannot filter water within 24 hours, short-term refrigeration for up to five days outperforms freezing as a storage option.20PubMed Central. Methods to maximise recovery of environmental DNA from water samples That last finding is counterintuitive; you might assume colder is always better, but freezing water samples can cause ice crystals to shear DNA strands.
Working in the tropics creates additional problems, since cold storage may not be available in remote field sites. Researchers have shown that adding a lysis buffer directly to filter cartridges after filtration prevents eDNA decline even when samples are stored at 40°C for a week, maintaining species detection by metabarcoding.21MethodsX. Preservation of filtered environmental DNA samples at ambient high temperatures Solutions like this have expanded eDNA surveys into equatorial regions where refrigeration logistics previously made the technique impractical.
Capillary Blood, Dried Spots, and Sampling Children
Drawing blood from infants and very young children presents unique challenges. Their veins are small and hard to access, and the procedure is distressing. Capillary blood, obtained by pricking a finger or heel, is often used instead. But capillary and venous blood are not identical. In a study of malaria diagnosis in children under two, capillary samples showed average parasite densities more than double those of paired venous samples from the same children.22Journal of Clinical Case Studies and Family Medicine. Evaluating the Accuracy of Venous and Capillary Blood Collection in Malaria Diagnosis in Children 0-2year Post Administration Sulfadoxine and Pyrimethamine in Selected Hospitals in the Metropolitan District of Sierra Leone This difference likely reflects the biology of malaria parasites sequestering in small blood vessels. For clinicians, it means the collection site itself can change the apparent severity of infection, and results from capillary and venous draws should not be treated as interchangeable for every test.
Dried blood spots take the simplicity of a finger prick even further. A few drops of blood are absorbed onto filter paper, dried, and mailed to a laboratory at room temperature. This approach has been used for newborn screening for decades and gained new attention during the COVID-19 pandemic as a way to test for antibodies without an in-person clinic visit. Research confirmed that dried blood spots showed high agreement with standard venous blood for detecting SARS-CoV-2 antibodies, though the measured antibody levels were slightly lower on average, creating some ambiguity right at the borderline between positive and equivocal results.23PubMed Central. Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing For surveillance purposes, where you mostly care whether someone has antibodies at all, that trade-off is acceptable. For clinical decisions that depend on precise antibody levels, it may not be.
Microbiology Specimens and Keeping Pathogens Alive
Most clinical specimens are collected so something inside them can be measured. Microbiology specimens have a different goal: they need to keep the pathogen alive and in detectable quantities long enough to reach the lab. Viruses are particularly demanding. They lack the ability to reproduce outside a host cell, and many lose their infectivity rapidly at room temperature. Transport media, special solutions designed to buffer the virus against environmental damage, have been formulated and refined over many decades. Studies on virus stability in transport media show that most tested viruses remain viable for one to three days under proper conditions.24PubMed Central. Transport of viral specimens That window sounds generous, but it can be tight in rural or resource-limited settings where a specimen collected on a Friday might not reach a reference lab until Monday.
Automation and Reducing Human Error
Given that the pre-analytical phase is where most errors originate, laboratories have increasingly turned to technology to take humans out of the equation where possible. Biometric patient identification (scanning a fingerprint or iris instead of relying on a wristband) eliminates mislabeling at the bedside. Barcode and RFID tracking follow a sample from the collection point through processing, flagging delays or temperature excursions automatically. Robotic phlebotomy devices, still mostly in development, aim to standardize the blood draw itself. A narrative review of these technologies found that they collectively reduce human errors, improve specimen traceability, and strengthen quality assurance across the pre-analytical workflow.25Apollo Medicine. Artificial Intelligence and Automation in Pre-analytical Phase of Laboratory Testing: A Narrative Review
Point-of-care testing takes a different approach to the same problem by eliminating transport altogether. If the analyzer sits next to the patient, there is no transit time, no pneumatic tube hemolysis, and no opportunity for a sample to be left on a counter. Simulation modeling has shown that for rural clinics testing conditions like pneumonia, point-of-care testing roughly halved the total lost productive hours compared to sending specimens to a central lab.26PubMed Central. Simulation Analysis and Comparison of Point of Care Testing and Central Laboratory Testing In hospital settings where a central lab is nearby, the advantage shrinks considerably. The value of point-of-care testing, in other words, scales with distance and delay.
Ethics of Collecting and Storing Human Specimens
Collecting a specimen from a person is not just a technical act; it raises ethical questions about consent, privacy, and future use. A blood sample drawn for a cholesterol check contains a person’s entire genome. A biopsy stored in a biobank could theoretically be analyzed for genetic predispositions the patient never consented to have examined. European frameworks for biobank governance have outlined detailed requirements to address these concerns: coded rather than named samples, robust data protection, ethics committee review on a case-by-case basis, the right to withdraw consent at any time, and opt-out procedures for secondary research uses.27PubMed Central. Legal & ethical compliance when sharing biospecimen
The concept of “broad consent” has emerged as a practical compromise for biobanks. Under broad consent, a participant agrees that their sample may be used for a range of future research purposes rather than a single defined study. This avoids the logistical impossibility of re-contacting thousands of donors every time a new research question arises, but it also means participants are consenting to uses they cannot yet imagine. Transparency measures, independent oversight, and meaningful participant involvement (such as community representatives serving on ethics committees) are considered essential safeguards.27PubMed Central. Legal & ethical compliance when sharing biospecimen Forensic toxicology adds another layer, where chain-of-custody documentation must prove a specimen was handled without opportunity for tampering from the moment of collection to the courtroom.28PubMed. Principles and procedures in forensic toxicology In that context, the integrity of the specimen is not just a scientific concern but a legal one, and a single break in documentation can render a result inadmissible.